Naphthalene
HERO ID
1422816
Reference Type
Book/Book Chapter
Year
2001
Language
English
| HERO ID | 1422816 |
|---|---|
| Year | 2001 |
| Title | Naphthalene |
| Book Title | Documentation of the threshold limit values and biological exposure indices |
| Authoring Organization | American Conference of Governmental Industrial Hygienists |
| Publisher Text | American Conference of Governmental Industrial Hygienists |
| City | Cincinnati, OH |
| Volume | Documentation of the threshold limit values and biological exposure indices Vol |
| Page Numbers | 1-4 |
| Abstract | The TLV-TWA 10 ppm (52 mg/m3) and TLV-STEL of 15 ppm (79 mg/m3) are recommended for occupational exposure to naphthalene. These values are intended to minimize the potential for eye and respiratory tract irritation and ocular toxicity that can include cataract formation, optical neuritis, lens opacities, and retinal degeneration. Other adverse effects may include headache, loss of appetite, nausea, and blood dyscrasia, such as hemolytic anemia and hemoglobinuria. Systemic poisoning following dermal contact and absorption of naphthalene warrants a Skin notation. Based on the very limited evidence of carcinogenicity in rodents, pulmonary adenomas in female mice but not in the male mice or in rats of either sex, exposed by inhalation for 2 years, an A4, Not Classifiable as a Human Carcinogen, notation is assigned. Sufficient data were not available to recommend a SEN notation. |
| Is Certified Translation | No |
| Dupe Override | No |
| Comments | Journal: ACGIH ISSN: |
| Is Public | Yes |
| Language Text | English |
| Keyword | <?xml version="1.0" encoding="UTF-8"?><kw>ANIMAL</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>acute toxicity</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>subacute toxicity</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>irritancy</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>carcinogenicity</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>genetic toxicity</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>reproductive and developmental tests</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>embryo-fetal toxicity</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>toxicokinetics</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>eye</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>HUMAN</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>case report</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>acute effect</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>chronic effect</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>irritancy</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>toxicokinetics</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>eye</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>respiratory system</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>blood</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>urinary tract</kw> |
| Relationship(s) |
|